Physically unclonable
with Unclonix
141 / Physical unclonable functions for real-world goods: how random particle patterns, optics, and multi-step scanning can strengthen product authenticity beyond plain QR codes. Discussion covers EU digital product passport rollout delays, Russia's Chestny ZNAK system, wine-bottle pilots, luxury use cases, and the tradeoff between scan convenience and clone resistance.
Timeline
Episode notes
Edit these notes…- Unclonix
- European commission: digital product passport package
- Chestny ZNAK
- US $100 bill security features
William Entriken talks with Martin Sandomirskii of Unclonix about whether physical unclonable labels can give stronger authenticity guarantees than plain QR workflows.
Core idea
- Martin Sandomirskii frames physical unclonable functions as fingerprint-like identifiers for products.
- The technical tradeoff is direct: easier scanning lowers verification friction, while stronger clone resistance usually needs higher-resolution optics and stricter capture conditions.
- The strongest claims are around random particle distributions that are hard to reproduce intentionally.
Standards and policy context
- The discussion compares EU digital product passport timelines with Russia’s already-deployed centralized marking model.
- The hosts also compare these systems with NFT-style custody tracking and one-to-one asset records.
- A recurring tension is interoperability: country-specific systems can still leave gaps at cross-border handoff points.
Product walkthrough and threat model
- Martin describes Unclonix labels as printed patterns plus random particles in a coating layer.
- William pressure-tests the threat model: label cloning, camera resolution limits, false confidence from easy smartphone checks, and production-line capture quality.
- Proposed mitigations include multi-image capture during production, human-visible 3D effects, and layered verification similar to banknote security.
Market focus discussed on-air
- Early traction is presented in wine and luxury goods, especially where brands dislike commodity-looking QR labels.
- Pharma is discussed as a high-stakes case because counterfeit risk and recall investigations can carry major legal and reputational costs.
- The host argues adoption value depends on whether anyone in that supply chain will actually perform verification scans.
Open items for human follow-up
- Confirm public discussion URL.